Clinical Trial Details

EORTC-30994

Back to Clinical Trials Database

Randomized phase III trial comparing immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4, and/or N+M0 transitional cell carcinoma (TCC) of the bladder

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 09-Oct-2001
Date Step1 close: 14-Aug-2008
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 660
Treatment Cisplatin, Doxorubicin, Gemcitabine, Methotrexate, Vinblastine
Study Staff
Type of cancer
Participating groups EORTC Genito-Urinary Cancers Group
NCIC Clinical Trial Group
Southwest Oncology Group-US
German Association of Urologic Oncology
Cancer Trials Support Unit
Groupe d'Etude des Tumeurs Uro-Genitales
National Cancer Research Institute - Bladder Cancer Group-UK
Protocol summary http://clinicaltrials.gov/ct/show/NCT00028756
NCT number NCT00028756
EudraCT 2005-003741-13